Cardiovascular disease remains a leading cause of premature mortality in Europe. Early identification of risk factors enables clinicians and patients to implement behavioural and therapeutic interventions that can reduce risk and promote healthier living. Emerging biomarkers, such as lipoprotein(a) and high-sensitivity C-reactive protein (hs CRP), offer valuable insights into subclinical cardiovascular risk.
Questionnaire
N/A
Measurements
Mandatory: N/A
Non-mandatory: N/A
Laboratory
Mandatory: Lipoprotein(a) and hs CRP
Non-mandatory: N/A
Interpretations
Flag assignment and report content are generated to reflect the relevant combinations of data inputs from laboratory results.🟢 Green flag: Indicates a normal hs CRP and lipoprotein(a).
🟡 Amber flag: Indicates a slightly high hs CRP or high lipoprotein(a).
🔴 Red flag: Indicates a high or very high hs CRP.